Bioequivalence data fabrication haunts drug makers
Published: 2008-06-20 07:00:00
Updated: 2008-06-20 07:00:00
The controversy over the bioequivalence data fabrication will flare again the Korea Medical Association plans to make public about a list of 500 medicines whose bioequivalence data were manipulated in collaboration with the research centers.
The KPA said that it will unveil the list on June 28...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
